This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Hainan Hdeton Science and Technology Co., Ltd., Lifearc, Meridian Laboratories, Inc.. Active years: 2013-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3 
1 out of 12 
1 out of 1 Years Active: 2013-2021
Title: Innovations by Inventor Ling Wu from Jiangsu, China
Introduction
Ling Wu is an accomplished inventor based in Jiangsu, China, known for her significant contributions to the field of pharmaceutical compounds. With a total of four patents under her name, she has made strides in developing innovative solutions for treating serious health conditions, including cancer and neurodegenerative diseases.
Latest Patents
Among her latest patents, the first one, titled "Substituted Tricyclic Heterocyclic Compounds and Use Thereof," details a substituted tricyclic heterocyclic compound that can be used in various pharmaceutical applications. This compound is crucial for addressing disorders related to cancer and neurodegenerative diseases, showcasing her commitment to advancing medical treatments.
The second patent, "Pharmaceutical Composition Containing Docetaxel-Cyclodextrin Inclusion Complex and its Preparing Process," describes a novel method for creating a docetaxel inclusion complex that has improved water solubility and stability. This innovation not only enhances the effectiveness of docetaxel but also outlines a detailed process for its preparation, reflecting Wu's expertise in pharmaceutical chemistry.
Career Highlights
Ling Wu has worked with reputable companies such as Hainan Hdeton Science and Technology Co., Ltd. and LifeArc, where her focus has been on drug development and innovation. Her career has been marked by a dedication to finding effective solutions for health issues, which is evident in her patent filings.
Collaborations
Throughout her career, Wu has collaborated with notable colleagues, including Yong Ren and Jianfeng Gao. These partnerships have helped her to further her research initiatives and enhance her contributions to the field of pharmaceuticals.
Conclusion
Ling Wu's inventive work in developing tricyclic heterocyclic compounds and docetaxel inclusion complexes marks her as a significant figure in the pharmaceutical industry. Her innovations are paving the way for new treatments that have the potential to improve the quality of life for patients battling serious diseases. With continued research and development, she is likely to make even more impactful contributions in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile